| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $41K | — |
| Cost of Revenue | $3K | — |
| R&D Expense | $15.9M | +24.2% |
| SG&A Expense | $5.4M | +23.7% |
| Operating Income | -$21.2M | -23.8% |
| Interest Expense | $674K | +221.2% |
| Net Income | -$21.0M | -22.1% |
| EPS (Basic) | -$0.18 | -20.0% |
| EPS (Diluted) | -$0.18 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.4M | +30.4% |
| Accounts Receivable | $30K | — |
| Current Assets | $32.7M | +29.0% |
| Total Assets | $41.8M | +42.8% |
| Current Liabilities | $2.6M | +71.7% |
| Total Liabilities | $5.3M | +212.8% |
| Stockholders' Equity | $36.4M | +32.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.2M | -16.9% |
| Capital Expenditures | $3.3M | +151.9% |
| Investing Cash Flow | -$3.0M | -33.8% |
| Financing Cash Flow | $22.5M | +68.8% |
| Free Cash Flow | -$15.5M | -31.9% |
| -20.0% |